New COPD treatment under safety watch in india
NCT ID NCT06531798
Summary
This study aims to monitor the safety and side effects of the Breztri inhaler when used as a long-term treatment for moderate-to-severe COPD. It will follow 150 Indian patients for about 6 months to see how well they tolerate the medication. The inhaler is already approved and available, so this research focuses on gathering more real-world safety information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.